Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

A group has developed therapies that show promise for treating cancer and various other conditions.

Stopping minoxidil caused significant hair loss, but regrowth occurred after resuming use.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Zidovudine may cause hair loss in advanced-stage HIV patients.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Leflunomide is more likely to help treat alopecia areata than cause it.

Higher antigliadin antibody levels are linked to alopecia areata severity.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Using old drugs for new uses can help treat rare immune deficiencies.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.